• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Latest

Where to Invest in 2021: Watch the Energy Sector and Cannabis Stocks

Like 0

By Lachlann Tierney, Tuesday, 24 November 2020

With a trio of vaccines on the cusp of being deployed, will 2021 be another everything rally year? Here are two investment themes that I think you should look out for...

In today’s Money Morning…gas has this one company flying…the other gas and hydrogen airplanes!?…pot stock craze to come back in 2021? I wouldn’t bet against it…and more…

Yesterday, my good friend Ryan Dinse boldly claimed that a ‘monkey with a dartboard could’ve made bank this year.’

And he’s certainly right, especially if you weren’t a big fund pouring money into ASX 200 stocks in January.

But today’s ‘third wave’ of positive vaccine news requires us to look further ahead.

As per the Australian Financial Review:

‘Pharmaceutical company AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90 per cent effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals…

‘AstraZeneca is the third major drug company to report late-stage results for a potential COVID-19 vaccine as the world anxiously waits for scientific breakthroughs that will bring an end to the pandemic.

‘Millions of doses of the Oxford vaccine are already in production in Melbourne at a CSL factory with plans to roll out vaccination in the coming months across Australia if it proves effective.

‘The Therapeutic Goods Administration has given it provisional approval and is awaiting data from AstraZeneca before granting the final tick.’

With a trio of vaccines on the cusp of being deployed, will 2021 be another everything rally year?

Here are two investment themes that I think you should look out for.

[conversion type=”in_post”]

Gas has this one company flying

This country’s energy policies are a constant sore spot.

We can’t seem to figure out exactly what we want to do.

Much of the discussion at the moment is focused on gas, which flows through to companies that can provide the gas.

Take a look at the daily chart for Senex Energy Ltd [ASX:SXY], for example:



Source: Tradingview.com

[Click to open in a new window]

That’s a pretty steady uptrend from the March lows for the nearly $500 million market-capped company.

But what are the prospects of a sustained push towards gas?

Well, a little birdy of mine at the top end of the superannuation industry says it’s more of ‘stop gap’ measure.

The bigger, more long-term story is about a different form of gas.

The other gas and hydrogen airplanes!?

Again, from the Australian Financial Review this morning:

‘Three of Australia’s gas chiefs told The Australian Financial Review Energy and Climate Summit the fuel had an important role to play as states side-step the federal government’s proposed gas-led recovery.

‘Tas Gas chief executive Phaedra Deckart said the proposed Marinus Link between Tasmania and the mainland was essential to shore the state up as the “battery of the nation”.

‘“The will is there to create a hydrogen industry for Australia,” Ms Deckart told the Summit. “With all of these technologies I think it’s important that we don’t pick winners, let’s fund and research and learn.”

‘Tasmania has thrown $50 million at developing hydrogen gas on the Apple Isle. Paraphrasing Mark Twain’s famous quote, Ms Deckart said, “Rumours of gas’ demise are greatly exaggerated.”’

Thrown into the mix is the fact airplane giant Airbus is planning to make a hydrogen-powered passenger aircraft a reality by 2035.

You can see a concept mock-up of what it would look like below:



Source: Airbus.com

[Click to open in a new window]

So, I’d be watching the energy space very closely in 2021, for these reasons.

Pot stock craze to come back in 2021? I wouldn’t bet against it

I’m noticing a lot of early speculative action on ASX-listed pot stocks at the moment.

For investors who remember, there was a pot stock boom back in 2017/18.

Here’s a chart that shows exactly how fast some of these stocks went up:



Source: Tradingview.com

[Click to open in a new window]

That big teal line is AusCann Group Holdings Ltd [ASX:AC8], the blue line is Medlab Clinical Ltd [ASX:MDC], and the red line is Cann Group Ltd [ASX:CAN].

All three companies spiked hard at the end of 2017.

AusCann traded at $1.74 in early 2018.

And now?

AusCann shares are going for around 13 cents, at time of writing.

As 2018 progressed there was a long painful share slide for these companies which left many investors who bought into the hype at the peak feeling burned.

Turns out, it’s incredibly difficult to sustain a successful cannabis business when Australian regulations remain tight.

But things could be changing.

For one, the Therapeutic Goods Administration (TGA) is due to make CBD oil available over the counter in February 2021.

This should expand the Australian medical cannabis market with current estimates of its size hovering around $40 million.

With recent developments in the US, it’s possible that 2020 was the bottom for these companies.

Time will tell of course, but these are just two investment themes that could burst onto the scene in 2021.

Act early, and you could be richly rewarded.

Regards,

Lachlann Tierney Signature

Lachlann Tierney,
For Money Morning

PS: Our publication Money Morning is a fantastic place to start on your investment journey. We talk about the big trends driving the most innovative stocks on the ASX. Learn all about it here.

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Lachlann Tierney
Lachlann ‘Lachy’ Tierney is passionate about uncovering hidden opportunities in the microcap sector. With four years of experience as a senior equities analyst at one of Australia’s leading microcap firms, he has built a reputation for rigorous research, deep-dive due diligence, and accessible investor communications. Over this time, he has vetted seed, pre-IPO and ASX-listed companies across sectors, conducted onsite visits, and built strong relationships across the microcap space. Lachy is nearing completion of a PhD in economics at RMIT University, where his research focuses on blockchain governance and voting systems. His work is housed within the Blockchain Innovation Hub at RMIT, a leading research centre for crypto-economics and blockchain research. He holds a Master’s degree from the London School of Economics and an Honours BA in Philosophy and Politics from the University of Melbourne. Born in New York and raised in California, Lachy grew up a few blocks from biotech giant Amgen and counts among his peers various characters in the overlapping worlds of venture capital, technology and crypto. When he’s not researching microcaps, he’s most likely sweating it out in a sauna or dunking himself in cold Tasmanian water.

Lachlann’s Premium Subscriptions

Publication logo
Australian Small-Cap Investigator
Publication logo
Fat Tail Microcaps
Publication logo
James Altucher’s Early-Stage Crypto Investor Australia

Latest Articles

  • AI: Productivity Boom or Employment Bust?
    By Charlie Ormond

    When AI Becomes ‘Corporate Ozempic’

  • The detail investors miss as gold and silver soar
    By Brian Chu

    Gold and silver are soaring, breaking to new highs every few weeks. While gold stocks are following suit, many will chase the winners that could cost them dearly. Avoid their mistake by doing this instead.

  • Forget American politics and read this: 3 tips for Australian investors, Pt. 3
    By Lachlann Tierney

    Thinking of investing in small caps or micro-caps? Learn what capital structure is and how it can help you make better investments. Lachlann Tierney tells you how.

Primary Sidebar

Latest Articles

  • AI: Productivity Boom or Employment Bust?
  • The detail investors miss as gold and silver soar
  • Forget American politics and read this: 3 tips for Australian investors, Pt. 3
  • Deep Water: The Future of Oil and Gas Exploration
  • Forget American politics and read this: 3 tips for Australian investors, Pt. 2

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988